$ELDN
Eledon Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEledon Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ELDN up today? It is at $2.50 (+2.04%), and our scanner flagged it 40 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ELDN spikes, and full due diligence on ELDN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ELDN 40 times in the last 30 days. Create a free account to track $ELDN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ELDN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ELDN today, peaking at 5.1x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Perrin Steven Officer | Acquired (grant/award) | +152K 0.2% of company | added 100% | 153K | n/a | Jul 31, 26 |
Perrin Steven Officer | Sold (automatic/other) | -72K 0.09% of company | sold 47% | 81K | $244K at $3.38 | Jul 31, 26 |
Gros David-Alexandre C Officer | Acquired (grant/award) | +354K 0.4% of company | added 100% | 363K | n/a | Jul 31, 26 |
Gros David-Alexandre C Officer | Sold (automatic/other) | -195K 0.2% of company | sold 54% | 169K | $658K at $3.38 | Jul 31, 26 |
Robinson James A. Jr. Director | Other | 3K | n/a | 3K | n/a | Jan 10, 26 |
Kirk Allan Director | Other | 3K | n/a | 3K | n/a | Jan 10, 26 |
Hillson Jan Director | Other | 3K | n/a | 3K | n/a | Jan 10, 26 |
Katkin Keith Director | Other | 9K 0.01% of company | n/a | 9K | n/a | Jan 10, 26 |
Mcbride John S. Director | Other | 3K | n/a | 3K | n/a | Jan 10, 26 |
Lee June Director | Other | 3K | n/a | 3K | n/a | Jan 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
ELDN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ELDN today, peaking at 5.1x its normal volume.
ELDN last traded at $2.50, up 2.04% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Eledon Pharmaceuticals, Inc. Common Stock (ELDN) is next expected to report earnings on Friday, November 13, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ELDN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ELDN 40 times in the last 30 days.
ELDN (Eledon Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $199M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ELDN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ELDN discussion
Sign in to ask a question or join the discussion.